-
EP4140492
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4140492
| EP4140492 - THERAPEUTIC POOLED BLOOD APOPTOTIC CELL PREPARATIONS AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 01.09.2023 Database last updated on 24.07.2024 | |
| Former | The application has been published Status updated on 27.01.2023 | Most recent event Tooltip | 13.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states ENLIVEX THERAPEUTICS RDO LTD 14 Einstein Street 7403618 Nes-Ziona / IL | [2023/09] | Inventor(s) | 01 /
MEVORACH, Dror 9574630 Jerusalem / IL | 02 /
NOVIK, Shai 4721249 Ramat Hasharon / IL | [2023/09] | Representative(s) | Pearl Cohen Zedek Latzer Baratz UK LLP The Gridiron Building One Pancras Square London N1C 4AG / GB | [2023/09] | Application number, filing date | 22194786.4 | 21.04.2016 | [2023/09] | Priority number, date | US201562150305P | 21.04.2015 Original published format: US 201562150305 P | [2023/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4140492 | Date: | 01.03.2023 | Language: | EN | [2023/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 05.01.2023 | Classification | IPC: | A61K35/17, A61K35/15, A61P37/00, A61K35/12, C12N5/078, A61K39/00 | [2023/09] | CPC: |
C12N5/0634 (EP,CN,IL,US);
A61K35/17 (KR,US);
C12N5/00 (CN);
A61K35/15 (KR,US);
A61K39/0008 (EP,IL,KR,US);
A61K39/461 (EP,CN,IL);
A61K39/4611 (KR);
A61K39/4613 (KR);
A61K39/4614 (KR);
A61K39/4615 (KR);
A61K39/4621 (EP,CN,IL,KR);
A61K39/46434 (EP,CN,IL,KR);
A61K39/4644 (EP,CN,IL,KR);
A61K9/0019 (IL,KR,US);
A61P29/00 (CN,KR);
A61P37/00 (EP,CN,IL,KR,US);
C12N5/0635 (KR);
C12N5/0639 (KR);
C12N5/0645 (KR);
C12N5/0646 (KR);
A61K2035/122 (EP,IL,KR,US);
A61K2039/515 (EP,IL,KR,US);
A61K2039/58 (EP,IL,KR,US);
A61K2239/31 (EP,CN,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/40] |
| Former [2023/09] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | THERAPEUTISCHE GEPOOLTE BLUTAPOPTOTISCHE ZELLPRÄPARATE UND VERWENDUNGEN DAVON | [2023/09] | English: | THERAPEUTIC POOLED BLOOD APOPTOTIC CELL PREPARATIONS AND USES THEREOF | [2023/09] | French: | PRÉPARATIONS THÉRAPEUTIQUES DE CELLULES APOPTOTIQUES SANGUINES GROUPÉES ET LEURS UTILISATIONS | [2023/09] | Examination procedure | 29.08.2023 | Amendment by applicant (claims and/or description) | 29.08.2023 | Examination requested [2023/40] | 29.08.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP16782737.7 / EP3285877 | Fees paid | Renewal fee | 09.09.2022 | Renewal fee patent year 03 | 09.09.2022 | Renewal fee patent year 04 | 09.09.2022 | Renewal fee patent year 05 | 09.09.2022 | Renewal fee patent year 06 | 09.09.2022 | Renewal fee patent year 07 | 14.03.2023 | Renewal fee patent year 08 | 13.03.2024 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO2004108753 (UNIV MELBOURNE [AU], et al); | [XY]WO2008056174 (AVARIS AB [SE], et al); | [Y]EP2201954 (APOSCIENCE AG [AT]); | [XDY]WO2014087408 (ENLIVEX THERAPEUTICS LTD [IL]); | [Y]WO2014106666 (INST NAT SANTE RECH MED [FR], et al); | by applicant | US2013156794 | WO2014087408 | WO2016170541 | WO2016IL50194 | WO2016IL50430 |